MS Patients Should Be Informed about Pregnancy Risks and Family Planning, Experts Say
SEPTEMBER 11, 2019 – BY ANA PENA, PHD of Medical News Today While pregnancy does not appear to affect the disease…
Ponesimod Bests Aubagio in Head-to-Head MS Trial
Investigational drug reduces annual relapse rate, shows effects on fatigue by Judy George, Senior Staff Writer, MedPage TodaySeptember 12, 2019 STOCKHOLM —…
Stuart Schlossman
#ECTRIMS2019 – Data Shows Ublituximab’s Long-term Safety in Relapsing MS, TG Therapeutics Announced
EXPERIMENTAL TREATMENTS FOR MS » UBLITUXIMAB (TGTX-1101) Ublituximab (TGTX-1101) is a glycoengineered anti-CD20 monoclonal antibody being developed by TG Therapeutics as a potential treatment for relapsing…
Stuart Schlossman
Genentech Presents New Six-Year Ocrevus (Ocrelizumab) Data Which Showed That Earlier Initiation and Continuation of Treatment Reduced Disability Progression in Multiple Sclerosis
SOUTH SAN FRANCISCO, Calif.–(BUSINESS WIRE)– – Post-hoc analysis from a Phase III open-label extension study showed a 42% reduction in…
Stuart Schlossman
Genentech to Present Pivotal Data for Satralizumab in Neuromyelitis Optica Spectrum Disorder and Six-year Ocrevus (Ocrelizumab) Data in Multiple Sclerosis at ECTRIMS
Published: Sep 04, 2019 Sept. 4, 2019 05:00 UTC Investigational medicine satralizumab significantly reduces the risk of relapse in pivotal…
Stuart Schlossman
Join us (in Columbus, OH) for a Special Roundtable discussion: “MS Conversations NOW” , with Aaron Boster, MD and an MS Patient Advocate
REGISTRATION NOW open for MS event called “MS Conversations NOW” RSVP for this Special RoundTable discussion with two special people…
Stuart Schlossman
Infusion Treatments: Benefits and Side Effects
Multiple sclerosis (MS) is an autoimmune disease that affects the central nervous system (CNS). With MS, your immune system mistakenly…
Stuart Schlossman
Novartis ofatumumab demonstrates superiority versus Aubagio® in two head-to-head Phase III multiple sclerosis studies
Aug 30, 2019 In ASCLEPIOS I and II, ofatumumab (OMB157) met primary endpoints to reduce the annualized relapse rate over…
Stuart Schlossman
Managing MS Symptoms and the Medications
A wide variety of medications are used to help manage the symptoms of MS. CLICK HERE to see common symptoms of MS…
Stuart Schlossman
MS Therapies Among Limited Offerings Through AllianceRx Walgreens Prime
August 16, 2019 Medications for treating certain rare and chronic conditions, including multiple sclerosis (MS), are now available from the…
Stuart Schlossman
